Markets

Will Ulta Salon and Nordstrom Help Solazyme's Anti-Aging Product Line Grow?

Source: .

Source: Algenist .

More important than the charts above about improving the "appearance" of skin is the brand's success with customers. Algenist sales have increased by 37%, 23%, and 21% in each of the last quarterly periods compared to the same period of the preceding year. It may appear that growth is slowing, but sales are growing from relatively low numbers that developed from scratch just a few years ago, which makes older growth look more astounding on a percentage basis. The brand reeled in $10.8 million in the first half of 2014 -- just the 10th and 11th quarters of commercial sales. However, it will need to do substantially better in the second half to reach sales targets for the year, which means investors are largely pinning their hopes on Ulta Salon and Nordstrom.

Can Algenist get back on track?

On the 2013 fourth-quarter conference call, Solazyme management told investors it expected 30% growth for Solazyme's health sciences unit, or SHS, in 2014. The business ended 2013 on a high note, growing nearly 21% for the entire year. That may have made 30% growth look quite feasible, especially when coupled with global store expansion, but Algenist sales are well off pace so far in 2014.

Consider that Algenist would need to turn in its two best quarters ever in the second half of 2014 to meet the expected 30% growth rate for the year. "Best quarters ever" means year-over-year growth of 36% and sales of at least $6.5 million. While the brand grew at 37% in the fourth quarter of 2013, it's important to remember the cyclical nature of consumer products and how the holiday seasons affect growth at the end of each year. In other words, 36% growth may be a bit of a reach; the brand appears to be on track for its historical annual growth rate of about 21%, which would fall nearly $1.8 million, or 7%, short of guidance.

2013 2014 % Growth
First Quarter $4 million $5 million 24%
Second Quarter $4.9 million $5.93 million 21%
Third Quarter $4.8 million $6.53 million* 36%*
Fourth Quarter $6.3 million $8.6 million* 36%*
---
Full Year $20 million $26 million* 30%*

*Needed to reach guidance. Source: Solazyme.

Of course, meeting the expectations set by management depends on how quickly that expansion occurs. CEO Jonathan Wolfson expects to have Algenist in over 2,000 stores worldwide by year-end, an increase of 54% from current store count. Simply putting the cosmetic brand on shelves at all Ulta Salon locations within the United States will expand total store count by over 40%. Factor in the new distribution deal with Nordstrom -- the first high-end retailer for Algenist -- and expansion with existing partners and it's easy to see the long-term potential for algae-powered cosmetics.

However, the expansion needed to achieve significant traction by now (early in the third quarter) for the additional stores to result in increased sales in the second half of 2014. Investors won't be able to gauge the success of expansion until third-quarter results are announced.

Will anti-aging cosmetics powered by algae succeed?

Solazyme's Algenist product line has been a wild success since launching 11 quarters ago. It went from a developmental product in March 2011 to a $20 million brand by the end of 2013. That's pretty spectacular sales and marketing progress in a historically difficult industry. Despite the potential for a miss on revenue targets in 2014, Algenist is growing handsomely in each quarterly period. I think it may simply be unrealistic to expect the brand to reach $26 million in sales in 2014. Whether or not Ulta Salon and Nordstrom prove me wrong on sales expectations, the potential for future revenue growth from Algenist presents a great high-margin backbone for Solazyme and a good opportunity for investors.

Top dividend stocks for the next decade

The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now .

The article Will Ulta Salon and Nordstrom Help Solazyme's Anti-Aging Product Line Grow? originally appeared on Fool.com.

Maxx Chatsko has no position in any stocks mentioned. Check out hispersonal portfolio,CAPS page,previous writing for The Motley Fool, or his work forSynBioBeta to keep up with developments in the synthetic biology industry. The Motley Fool recommends Ulta Salon, Cosmetics & Fragrance. The Motley Fool owns shares of Solazyme. Try any of our Foolish newsletter services free for 30 days . We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy .

Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ULTA JWN

Other Topics

Stocks

Latest Markets Videos

    The Motley Fool

    Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

    Learn More